Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-10-032020
Filing Date
2010-06-02
Accepted
2010-06-02 16:48:22
Documents
3
Effectiveness Date
2010-06-02

Document Format Files

Seq Description Document Type Size
1 DEFA14A a10-9595_22defa14a.htm DEFA14A 44543
2 GRAPHIC g959522bci001.jpg GRAPHIC 3139
3 GRAPHIC g959522bci002.jpg GRAPHIC 2123
  Complete submission text file 0001104659-10-032020.txt   53482
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

EIN.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-14680 | Film No.: 10873400
SIC: 2836 Biological Products, (No Diagnostic Substances)